Trial Profile
A study investigating the biodistribution and radiation dosimetry of 68Ga-ABY-025 in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Anti HER2 small molecule imaging agent (Primary)
- Indications Advanced breast cancer
- Focus Diagnostic use; Pharmacokinetics
- 25 May 2017 New trial record